…which f) the FDA is not going to sign off on and g) which you won’t hear Rep. Brad Daw, Sen. Evan Vickers, the UMA Eagle Forum or the Weber Country Sheriff praising.
It’s also answers observation in yesterday’s blogged article about whether or not Daw and Vickers’ 2018 bills will be of any help to more than a few possible patients, or even muddy the waters further.
Dr. Perry Renshaw, one of two U. of Utah psychiatry professors overseeing the research under the HB130 program repeated the old (and manifestly inaccurate) refrain that “There have been very few high-quality, placebo-controlled trials of substances that are known to have a (consistent) content of THC or (CBD).”
And yet here’s just such a large scale study. We’ll lay odds on either the Rep. or the doc here finding the results of this and equally impressive studies to be significant and meriting looking at reform movement in a positive and patient-centric light.
“…the largest study to be conducted in regards to the safety of using medical marijuana long term.
Effectively, they found that there are not really any serious adverse effects.
The team at Research Institute of the McGill Univ. in Montréal, Canada, have been doing research on the long-term safety of medical marijuana. They collected a group of 215 people with whose chronic pain they were going to treat with marijuana to use as their test group. They had a control group of 216.
The Canadian team treated their patients with 12% potency THC cannabis, and patients were allowed to choose whether they wanted to smoke, vaporize or ingest with edibles. Patients were using 2.5 grams a day over the period of an entire year. The group of patients using cannabis in the study were, however, familiar with cannabis use and had used it in the past to treat symptoms.
‘This is the first and largest study of the long-term safety of medical cannabis use by patients suffering from chronic pain ever conducted,’ said the lead author Dr. Ware. The study had centers all over Canada, in Fredericton, Halifax, London, Montreal, Toronto and Vancouver.”
More in the article….
Seriously, the jig is up on the “we need more research,” “we don’t know anything about dosing,” “all the evidence is anecdotal,” and “what about the long-term effects” crowds. That is, they’ll bleating these things, but they don’t hold water as coherent reasons for opposition in 2018 in a country where most people can now legally gain safe, legal and affordable access.
#MMJ #Research #LongTerm #SafeLegalAffordable #UTpol #TRUCE